Nightingale Health Plc – Managers’ transactions – Teemu Suna

Nightingale Health Plc – Managers' Transactions – 31 October 2022 2.30 p.m. (EET)

____________________________________________

Person subject to the notification requirement

Name: Suna, Teemu

Position: Chief Executive Officer

Issuer: Nightingale Health Oyj

LEI: 743700WUIPC24LVMLO66

Notification type: INITIAL NOTIFICATION

Reference number: 20698/7/6

____________________________________________

Transaction date: 2022-10-28

Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)

Instrument type: SHARE

ISIN: FI4000490875

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 331 Unit price: 1.16 EUR

(2): Volume: 8,169 Unit price: 1.16 EUR

Aggregated transactions

(2): Volume: 8,500 Volume weighted average price: 1.16 EUR

For further information, please contact:

Teemu Suna, CEO
ir@nightingalehealth.com

Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670

About Nightingale Health

Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it’s also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.

Tags: